The stuff that ‘makes magic mushrooms so magic’ moves closer to FDA approval for treating depression

psilocybin magic mushrooms
"Liberty cap" psilocybin mushrooms. Image credit: Scienceman71/Wikimedia

The active ingredient that makes magic mushrooms so magic—the psychedelic drug psilocybin—is one step closer to becoming a legal treatment for difficult cases of depression. [October 23] the company Compass Pathways announced that it had received the Food and Drug Administration’s Breakthrough Therapy designation for its psilocybin-based treatment. The designation will fast track the FDA’s review of the treatment for possible approval.

While many people who have recreationally taken psilocybin and other mind-altering drugs can attest to the positive feelings they leave behind, research into these drugs’ possible mental health benefits has been stifled for decades.

[I]n recent years, doctors, patients, and even pharmaceutical companies have slowly begun to convince the government to reconsider its stance, aided by small pilot studies showing that these drugs, usually in “microdoses” smaller than a person would take recreationally, can help treat depression, anxiety, and even drug addiction

ADVERTISEMENT

Related article:  Machines that decide ‘who lives and who dies’? AI community pledges never to build them
[S]tudies in the UK and U.S. have found that it could treat people with depression who haven’t responded well to other treatments. And Compass is set to fund the first large-scale trial of psilocybin that will run in North America and Europe over the next year, according to the company.

“We are excited to be taking this work forward with our clinical trial on psilocybin therapy for treatment-resistant depression,” said [Compass chairman] George Goldsmith.

Read full, original post: The Main Ingredient in Psychedelic Mushrooms Is Closer to Becoming an FDA-Approved Depression Treatment

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
seralinistud

Gilles-Éric Séralini: Activist professor and face of anti-GMO industry

The French biologist and his research team--funded by the Rodale ...
vandana shiva

Vandana Shiva: ‘Rock Star’ of GMO protest movement has anti-science history

In a 2012 interview, Bill Moyers referred to Vandana Shiva as ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend